Ralph Brandenberger
Known title: See RemarksCIK: 0001853197
Associated companies
Transaction History
| NKTX | ▼ Sell | Open Market | 7,447 | $16K | 1/15/2025 | View on chart |
| NKTX | ▲ Buy | Grant | 52,500 | $0 | 1/3/2025 | View on chart |
| NKTX | ▼ Sell | Open Market | 229 | $1K | 6/18/2024 | View on chart |
| NKTX | ▲ Buy | Option Exercise | 3,808 | $15K | 3/1/2024 | View on chart |
| NKTX | ▲ Buy | Option Exercise | 2,955 | $11K | 3/1/2024 | View on chart |
| NKTX | ▼ Sell | Open Market | 8,367 | $105K | 3/1/2024 | View on chart |
| NKTX | ▼ Sell | Open Market | 2,512 | $22K | 1/16/2024 | View on chart |
| NKTX | ▲ Buy | Grant | 56,000 | $0 | 1/4/2024 | View on chart |
| NKTX | ▼ Sell | Open Market | 221 | $1K | 6/20/2023 | View on chart |
| NKTX | ▼ Sell | Open Market | 491 | $3K | 1/17/2023 | View on chart |
| NKTX | ▲ Buy | Grant | 21,000 | $0 | 1/13/2023 | View on chart |
| NKTX | ▲ Buy | Option Exercise | 842 | $3K | 10/6/2022 | View on chart |
| NKTX | ▼ Sell | Open Market | 842 | $12K | 10/6/2022 | View on chart |
| NKTX | ▼ Sell | Open Market | 11,000 | $194K | 8/15/2022 | View on chart |
| NKTX | ▲ Buy | Option Exercise | 11,000 | $43K | 8/15/2022 | View on chart |
| NKTX | ▲ Buy | Option Exercise | 4,367 | $2K | 8/8/2022 | View on chart |
| NKTX | ▲ Buy | Option Exercise | 340 | $2K | 8/8/2022 | View on chart |
| NKTX | ▼ Sell | Open Market | 11,593 | $180K | 8/8/2022 | View on chart |
| NKTX | ▲ Buy | Option Exercise | 6,886 | $27K | 8/8/2022 | View on chart |
| NKTX | ▲ Buy | Option Exercise | 3,000 | $1K | 7/25/2022 | View on chart |
| NKTX | ▼ Sell | Open Market | 3,000 | $40K | 7/25/2022 | View on chart |
| NKTX | ▲ Buy | Grant | 2,500 | $0 | 6/17/2022 | View on chart |
| NKTX | ▲ Buy | Option Exercise | 1,358 | $5K | 6/3/2022 | View on chart |
| NKTX | ▲ Buy | Option Exercise | 405 | $2K | 6/3/2022 | View on chart |
| NKTX | ▲ Buy | Option Exercise | 2,037 | $8K | 6/3/2022 | View on chart |
| NKTX | ▼ Sell | Open Market | 4,140 | $62K | 6/3/2022 | View on chart |
| NKTX | ▲ Buy | Option Exercise | 340 | $139 | 6/3/2022 | View on chart |
| NKTX | ▲ Buy | Grant | 5,300 | $0 | 1/14/2022 | View on chart |
| NKTX | ▲ Buy | Option Exercise | 340 | $139 | 12/1/2021 | View on chart |
| NKTX | ▲ Buy | Option Exercise | 405 | $2K | 12/1/2021 | View on chart |
| NKTX | ▲ Buy | Option Exercise | 1,358 | $5K | 12/1/2021 | View on chart |
| NKTX | ▲ Buy | Option Exercise | 2,037 | $8K | 12/1/2021 | View on chart |
| NKTX | ▼ Sell | Open Market | 4,140 | $65K | 12/1/2021 | View on chart |
| NKTX | ▲ Buy | Option Exercise | 340 | $139 | 9/1/2021 | View on chart |
| NKTX | ▲ Buy | Option Exercise | 405 | $2K | 9/1/2021 | View on chart |
| NKTX | ▲ Buy | Option Exercise | 1,358 | $5K | 9/1/2021 | View on chart |
| NKTX | ▲ Buy | Option Exercise | 2,037 | $8K | 9/1/2021 | View on chart |
| NKTX | ▼ Sell | Open Market | 4,140 | $133K | 9/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 28, 2026
Nkarta Sets 2026 Data Reveal as CAR NK Trials Progress
Nkarta announced that it is targeting a data reveal for its outpatient CAR NK trials in 2026. The company said the trials are advancing, indicating progress toward a potential regulatory milestone. This development may influence how the market views the company’s future prospects. The stock is currently trading near its support level of $2.61.
Nkarta Sets 2026 Data Reveal as CAR NK Trials Progress. Nkarta announced that it is targeting a data reveal for its outpatient CAR NK trials in 2026. The company said the trials are advancing, indicating progress toward a potential regulatory milestone. This development may influence how the market views the company’s future prospects. The stock is currently trading near its support level of $2.61.